JP2008522613A5 - - Google Patents

Download PDF

Info

Publication number
JP2008522613A5
JP2008522613A5 JP2007545384A JP2007545384A JP2008522613A5 JP 2008522613 A5 JP2008522613 A5 JP 2008522613A5 JP 2007545384 A JP2007545384 A JP 2007545384A JP 2007545384 A JP2007545384 A JP 2007545384A JP 2008522613 A5 JP2008522613 A5 JP 2008522613A5
Authority
JP
Japan
Prior art keywords
point
give
bases
points
given
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007545384A
Other languages
English (en)
Japanese (ja)
Other versions
JP4672021B2 (ja
JP2008522613A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2005/004207 external-priority patent/WO2006062369A1/en
Publication of JP2008522613A publication Critical patent/JP2008522613A/ja
Publication of JP2008522613A5 publication Critical patent/JP2008522613A5/ja
Application granted granted Critical
Publication of JP4672021B2 publication Critical patent/JP4672021B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007545384A 2004-12-08 2005-12-08 標的ｍＲＮＡと相補的な塩基配列を有するｓｉＲＮＡを用いて標的ｍＲＮＡの発現を抑制する方法 Expired - Fee Related JP4672021B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20040103283 2004-12-08
PCT/KR2005/004207 WO2006062369A1 (en) 2004-12-08 2005-12-08 Method of inhibiting expression of target mrna using sirna consisting of nucleotide sequence complementary to said target mrna

Publications (3)

Publication Number Publication Date
JP2008522613A JP2008522613A (ja) 2008-07-03
JP2008522613A5 true JP2008522613A5 (https=) 2011-01-13
JP4672021B2 JP4672021B2 (ja) 2011-04-20

Family

ID=36578152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007545384A Expired - Fee Related JP4672021B2 (ja) 2004-12-08 2005-12-08 標的ｍＲＮＡと相補的な塩基配列を有するｓｉＲＮＡを用いて標的ｍＲＮＡの発現を抑制する方法

Country Status (6)

Country Link
US (1) US20090155904A1 (https=)
EP (1) EP1828415A4 (https=)
JP (1) JP4672021B2 (https=)
KR (1) KR101007346B1 (https=)
CN (1) CN101120099B (https=)
WO (1) WO2006062369A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
CN105176999A (zh) * 2015-08-13 2015-12-23 吉林大学 抑制survivin基因表达的双链siRNA、其应用及包含其的表达质粒及传递体
CN105063048A (zh) * 2015-08-13 2015-11-18 吉林大学 一种抑制Survivin基因表达的siRNA及其应用
CN112951322B (zh) * 2021-03-08 2023-09-26 深圳市新合生物医疗科技有限公司 一种基于网格搜索的规则权重分配siRNA设计方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1427008A (zh) * 2001-12-14 2003-07-02 殷冬生 设计与选择天然的siRNA作为基因药物的方法及药物配方
US20040002083A1 (en) * 2002-01-29 2004-01-01 Ye Ding Statistical algorithms for folding and target accessibility prediction and design of nucleic acids
AU2003295600A1 (en) * 2002-11-14 2004-06-15 Dharmacon, Inc. Functional and hyperfunctional sirna

Similar Documents

Publication Publication Date Title
USD544972S1 (en) Portable lamp
FR2866387B1 (fr) Adaptation aerodynamique de la soufflante arriere d'un turboreacteur double soufflante
JP2001354559A5 (https=)
JP2004532810A5 (https=)
JP2004529078A5 (https=)
JP2004523498A5 (https=)
JP2006517944A5 (https=)
JP2008532951A5 (https=)
JP2008513560A5 (https=)
JP2009520682A5 (https=)
ATE290534T1 (de) 4-(oxadiazol-3-yl)-1,4-diazabizyklo(3.2.2)- nonanderivate, ihre herstellung und therapeutische verwendung
JP2006052402A5 (https=)
JP2007510403A5 (https=)
JP2010501017A5 (https=)
JP2008534513A5 (https=)
JP2008522613A5 (https=)
JP2008517002A5 (https=)
JP2008546803A5 (https=)
JP2009019158A5 (https=)
JP2006516021A5 (https=)
JP2007518719A5 (https=)
JP2006500360A5 (https=)
IS7705A (is) 4-(3,5-Dísýanófenoxý) pýrasól afleiður til notkunar sem bakritunarstillar við meðhöndlun á m.a. eyðniveirunni
JP2007512260A5 (https=)
JP2005298393A5 (https=)